nortriptyline has been researched along with Suicidal Ideation in 2 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Suicidal Ideation: A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD)." | 6.90 | Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. ( Aitchison, KJ; Behrendt-Møller, I; Buttenschøn, HN; Dernovsek, MZ; Hauser, J; Henigsberg, N; Köhler-Forsberg, O; Madsen, T; Maier, W; McGuffin, P; Mors, O; Perroud, N; Rietschel, M; Souery, D; Uher, R, 2019) |
| " The aim of the present genome-wide association study was to identify additional genetic variants involved in increasing suicidal ideation during escitalopram and nortriptyline treatment." | 5.16 | Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. ( Aitchison, KJ; Breen, G; Craig, IW; Dernovsek, MZ; Farmer, A; Gennarelli, M; Guipponi, M; Hauser, J; Henigsberg, N; Lathrop, M; Lewis, CM; Maier, W; McGuffin, P; Mors, O; Ng, MY; Perroud, N; Rietschel, M; Souery, D; Stamp, AS; Uher, R, 2012) |
| "Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD)." | 2.90 | Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. ( Aitchison, KJ; Behrendt-Møller, I; Buttenschøn, HN; Dernovsek, MZ; Hauser, J; Henigsberg, N; Köhler-Forsberg, O; Madsen, T; Maier, W; McGuffin, P; Mors, O; Perroud, N; Rietschel, M; Souery, D; Uher, R, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madsen, T | 1 |
| Buttenschøn, HN | 1 |
| Uher, R | 2 |
| Behrendt-Møller, I | 1 |
| Perroud, N | 2 |
| Maier, W | 2 |
| Hauser, J | 2 |
| Dernovsek, MZ | 2 |
| Henigsberg, N | 2 |
| Souery, D | 2 |
| Rietschel, M | 2 |
| McGuffin, P | 2 |
| Aitchison, KJ | 2 |
| Mors, O | 2 |
| Köhler-Forsberg, O | 1 |
| Ng, MY | 1 |
| Guipponi, M | 1 |
| Gennarelli, M | 1 |
| Stamp, AS | 1 |
| Lathrop, M | 1 |
| Farmer, A | 1 |
| Breen, G | 1 |
| Lewis, CM | 1 |
| Craig, IW | 1 |
2 trials available for nortriptyline and Suicidal Ideation
| Article | Year |
|---|---|
Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Europe; Female; Humans; Male; | 2019 |
Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Genome-Wide Asso | 2012 |